Hartline Investment Corp’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,434
Closed -$253K 118
2022
Q3
$253K Buy
+12,434
New +$248K 0.21% 112

Other funds holding BTAL

Hartline Investment Corp's BTAL Position: Q4 2022 in Review

Hartline Investment Corp sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2022, closing a stake of 12,434 shares — an estimated $253K sold.

Hartline Investment Corp first reported a position in BTAL in Q3 2022 and held it in 1 quarter. The position peaked at $253K in Q3 2022. 80 funds tracked by Wall St. Rank hold BTAL as of Q4 2022.

  • Hartline Investment Corp reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2022 after selling out during the quarter.
  • Hartline Investment Corp sold 12,434 AGF US Market Neutral Anti-Beta Fund shares in Q4 2022, an estimated $253K.
  • Hartline Investment Corp first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 1 quarter.
  • Hartline Investment Corp's AGF US Market Neutral Anti-Beta Fund position peaked at $253K in Q3 2022.
  • 80 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2022.

Based on Hartline Investment Corp's 13F filing for Q4 2022, filed 6 Feb 2023.